Cooper Companies (NASDAQ: COO) Stock Analysis: Price Target, Performance, and Insider Buying

• Cooper Companies (NASDAQ: COO), a major provider of contact lenses and women’s health products, received a $60 price target from Barclays, representing potential upside from its $56.43 closing price.

• The stock closed down 0.60% at $56.43. Its 52-week range of $51.01 to $89.83 places the shares significantly closer to their yearly low.

• Director Lawrence Erik Kurzius purchased 10,000 shares for $549,320, while the company reported trailing-12-month revenue of approximately $4.2 billion and net income of $570.3 million.

Cooper Companies (NASDAQ: COO) makes contact lenses through CooperVision and provides women’s health and fertility products through CooperSurgical. Barclays initiated coverage of the stock with an Equal Weight rating and a $60 price target. Based on the quoted price of $56.43, the target is $3.57 higher, representing potential upside of approximately 6.3%. A price target is an analyst’s estimate, not a guaranteed future price.

COO closed down $0.34, or 0.60%, at $56.43 on October 6, 2026. The stock traded between $55.64 and $56.93 during the session, with approximately 4 million shares changing hands. Its 52-week range is $51.01 to $89.83, placing the current price much closer to its yearly low than its high.

Director Lawrence Erik Kurzius purchased 10,000 COO shares on September 16, 2026, at an average price of $54.93 per share, according to an SEC filing. The transaction totaled $549,320 and increased his direct holdings to 31,099 shares. This followed another purchase of 10,000 shares on September 14 at an average price of $53.91 per share.

Cooper reported approximately $4.2 billion in revenue and $570.3 million in net income over the 12 months ended July 31, 2026. Revenue represents the money generated from sales, while net income is the amount remaining after expenses and taxes. The company’s market capitalization was approximately $10.7 billion as of October 6, 2026.